Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?

By Dhalla Fatima   Lucas Mary   Schuh Anna   Bhole Malini   Jain Rashmi   Patel Smita   Misbah Siraj   Chapel Helen  

Journal of Clinical Immunology, Vol. 34, Iss. 3, 2014-04 ,pp. : 277-282

Springer Publishing Company

Access to resources Recommend Favorite

Circulating endothelial cells in patients with chronic lymphocytic leukemia

By Go Ronald  

Annals of Hematology, Vol. 87, Iss. 5, 2008-05 ,pp. : 369-373

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells

By Stanglmaier Michael  

Annals of Hematology, Vol. 83, Iss. 10, 2004-10 ,pp. : 634-645

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenesis in Chronic Lymphocytic Leukemia

By  

Current Angiogenesis, Vol. 2, Iss. 2, 2013-09 ,pp. : 96-103

Bentham Science Publishers

Access to resources Recommend Favorite

New aspects on the pathogenesis, diagnostic procedures, and therapeutic management of chronic lymphocytic leukemia

By Wendtner Clemens-Martin   Schmitt Barbara   Bergmann Manuela   Röhnisch Tim   Buhmann Raymund   Hallek Michael  

International Journal of Hematology, Vol. 73, Iss. 1, 2001-01 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite